Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes

Journal of Translational Medicine

Abdalla Bowirrat²  Zaher Armaly²  Orna Baron-Epel¹  Lubna Hafi¹  Bishara Bisharat² 

[1] School of Public Health Haifa University, Haifa, Israel;Department of Internal Medicine and Clinical Neuroscience, EMMS Nazareth-The Nazareth Hospital, Nazareth 16100, Israel

关键词: Medication adherence;    Cardiac patients;    Pharmacist intervention;   

Others  :  1206047
DOI  :  10.1186/1479-5876-10-34

 received in 2011-11-13, accepted in 2012-03-01,  发布年份 2012

【 摘 要 】

Background

Medication non adherence is a global epidemic perplexing phenomenon that is eminent, but not insurmountable. Our first objective was to explore whether providing pharmacist's counseling to cardiac patients prior to discharge can increase patient's medication adherence, and our second objective was to assess whether better medication adherence leads to reduction of hospital readmissions.

Methods

Observational study was conducted among diagnosed cardiac patients using an intervention strategy at discharge from two hospitals in Israel; The Nazareth and the Haemek hospital. 74 patients were recruited between January 2010 and January 2011. Two separate groups were selected; intervention group: 33 patients who prior to discharge received nurse, pharmacist interventions, and control group: 41 patients who had received the nurse and hospital discharge counseling only.

Results

Regression analysis for examining the first objective reflected significant effect when having a pharmacist interventions, which explains the increasing 11.6% of the variance in medication adherence, [F change (1,73) = 9.43, p < 0.003]. Stepwise regression analysis for examining the second objective demonstrated that the relation between medication adherence and readmissions was insignificant [F _(1,73) = 9.43, n.s].

Conclusions

While physicians and nurses can have an impact on improving adherence, pharmacists have demonstrated the ability to inform, problem-solve and provide performance support directly to patients.

【 授权许可】

   
2012 Bisharat et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Russell S, Daly J, Hughes E, op't-Hoog C: Nurses and 'difficult' patients: negotiating non-adherence. JAN 2003, 43:281-287.
• [2]Amaral P: The special case of compliance in the elderly. In Compliance: the dilemma of the chronically ill. Edited by Gerber K, Nehemkis A. New York: Springer; 1986.
• [3]World Health Organization: Adherence to long-term therapies: evidence for action. 2003. Available from: [http://apps.who.int/medicinedocs/en/d/Js4883e/5.html webcite] (last accessed 18th April 2010)
• [4]Frost & Sullivan's. 6th Annual Patient Adherence Congress March 10, 2011, the Union League, Philadelphia, PA. [http://www.frost.com]
• [5]Cabezas C, Salvador C, Quadrada D, Bartes A, Bore M, Perea N, Peipoch E: Randomized clinical trial of a post-discharge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp 2006, 30:328-342.
• [6]Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC: Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Therapeut 2009, 85:651-658.
• [7]Sadik A, Yousif M, McElnay J: Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol 2005, 60:183-193.
• [8]Urquhart J: Some economic consequences of nonadherance. Curr Hypertens Rep 2001, 3:473-480.
• [9]Wu J, Moser D, Chung M, Lennie T: Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 2008, 14:203-210.
• [10]Kerzman H, Baron-Epel O, Toren O: What do discharged patients know about their medication? Patient Educ Couns 2004, 2004(56):276-282.
• [11]Jin J, Sklar GE, Sen-Oh VM, Chuen-Li S: Factors affecting therapeutic adherance: a review from the patient's perspective. The Clin Risk Manag 2008, 4:269-286.
• [12]Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl J, Wu AW: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000, 12:255-266.
• [13]Dilorio C, Yeager K, Shafer PO, Letz R, Henry T, Schomer DL, McCarty F: The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs 2003, 35:155-162.
• [14]Dilorio C, Faherty B, Manteuffel B: Cognitive-perceptual factors associated with antiepileptic medication compliance. Res Nurs Health 1991, 14:329-338.
• [15]Graveley EA, Oseasohn CS: Multiple drug regimens: medication compliance among veterans 65 years and older. Res Nurs Health 1991, 14:51-58.
• [16]Andrade SE: Discontinuation of antihyperlipidemic drugs. Do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995, 332:1125-1131.
• [17]Bloom BS: Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998, 20:671-681.
• [18]Sidel J: Shaping the healthcare environment through evidence based medicine: a case study of the ICONS project. Hosp Quart 1998, 2:29-33.
• [19]Sullivan SD, Kreiling DH, Hazlet TK: Nonadherance with medication regimens and subsequent hospitalizations: literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1990, 2:19-33.
• [20]Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986, 24:67-74.
• [21]McLean W: An adherence study of prescription refill data, with and without a periodic patient education program. Car Pharm J 2007, 140:104-106.
• [22]Rosenstock IM: Historical origins of the health belief model. Health Educ Monogr 1974, 2:328-335.
• [23]Chabot I, Moisan J, Gregoire JP, Milot A: A pharmacist intervention program for control of hypertension. Ann Pharmacother 2003, 37:1186-1193.
• [24]Côte I, Gregoire JP, Moisan JA: A pharmacy-based health promotion program in hypertension: cost-benefit analysis. PharmacoEconomics 2003, 21:415-428.
• [25]Galt KA: Cost avoidance, acceptance and outcomes associated with a pharmacotherapy consult clinic in a veteran's affairs medical center. Pharmacotherapy 1998, 18:1103-1111.
• [26]Munroe WP, Kunz K, Dalmady-Israel C: Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997, 19:113-123.
• [27]Poston J: The medication use study: a large-scale controlled evaluation of the effects of the vital interests program on adherence to medication regimens. Can Pharm J 1999, 123:31-38.
• [28]George J, Phun YT, Bailey MJ, Kong DC, Stewart K: Development and validation of the medication regimen complexity index. Ann Pharmacother 2004, 38:1369-1376.
• [29]Berk M, Berk L: Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events. Ann Clin Psychiatry 2003, 15:217-224.
• [30]AdheranceThe Merck Manual of Diagnosis and Therapy, section 19, Chapter 258, Drug Treatment in Newborns, Infants, and Children. Available at www.merck.com webcite
• [31]Jones G: Prescribing and taking medicines. BMJ 2003, 327:819-820.
• [32]Morris LS, Schulz RM: Patient adherence--an overview. J Clin Pharm Ther 1992, 17:283-295.
• [33]McDonald HP, Garg AX, Haynes RB: Interventions to enhance patient adherence to medication prescriptions. JAMA 2002, 288:2868-2879.
• [34]World Health Organization: Adherence to Long-Term Therapies: evidence for Action. Geneva: World Health Organization; 2003.
• [35]Calabrese A, Cholka K, Lenhart S, McCarty B, Zewe G, Sunseri D, Roberts M, Kapoor W: Pharmacist involvement in a multidisciplinary inpatient medication education program. Am J Health-Syst Pharm 2003, 60:1012-1018.
• [36]Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shelvin M: Medication adherance: a healthcare problem. Ann Pharmacother 1993, 27:5-19.
• [37]Greenburg RN: Overview of patient adherence with medication dosing: a literature review. Clin Ther 1984, 6:591-599.
• [38]Sipkoff M: The newsletter of quality issues in health care. Quality Indicator 2001.
• [39]Dunbar-Jacob J, Mortimer-Stephens MK: Treatment adherence in chronic disease. J Clin Epidemiol 2001, 54:57-60.
• [40]Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R: Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2000, 2:CD000011.
• [41]Roter DL, Hall JA, Merisca B, Nordstrom D, Cretin B: Effectiveness of interventions to improve patient adherence: a meta-analysis. Med Care 1998, 36:1138-1161.
• [42]Ellis S, Shumaker S, Sieber W, Rand C: Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials 2000, 21:218-225.
• [43]Jackevicius CA, Mamdani M, Tu JV: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-467.
• [44]Benner JS, Glynn RJ, Neumann PJ, Mogun H, Weinsten MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-461.
• [45]Haynes RB: Improving patient adherence. In State of the art, with a special focus on medication taking for cardiovascular diseases. Edited by Burke LE, Ockene IS. Armonk: Adherance in Healthcare and Research. Futura Publishing; 2001.
• [46]Volmink J, Garner P: Systematic review of randomized controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 1997, 315:1403-1406.
• [47]Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999, 21:1074-1090.
• [48]Turner BJ, Hecht FM: Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 2001, 134:1004-1006.
• [49]Vitolins MZ, Rand CS, Rapp SR, Ribisi PM, Sevick MA: Measuring adherence to behavioral and medical interventions. Control Clin Trials 2000, 21:188-194.